Dr. Arun Maseeh, VP Medical Services is showing Polycap !!
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
About Polycap
- Polycap or Polypill is a 5-in-1
- capsule (or pill) developed by Cadila Pharmaceuticals Ltd.India. It's a miracle combination of Atenolol (50 mg), Thiazide (12·5 mg), Ramipril (5 mg), Simvastatin (20 mg) and Aspirin (100 mg) for primary prevention of cardiovascular events and stroke. The Indian Polycap study data was published in Lancet and presentation in the ACC 09 by Dr. Salim Yusuf of Mc Master University, Canada and Dr. Prem Pais of St. John’s Medical College, Bangalore on behalf of the Polycap investigators. “This study was entirely funded by Cadila Pharmaceuticals as contribution towards our goal of reducing the global burden of disease” said Cadila Pharmaceuticals chairman Shri I.A.Modi.
Quick links
World Speaks
Contact Us
Corporate & Registered Office
Cadila Corporate Campus
Sarkhej-Dholka Road,
Bhat, Ahmedabad-382 210, INDIA
Phone : +91-2718-225001 (15 Lines)
Fax :+91-2718-225039
e-mail : response@cadilapharma.co.in
http://www.polycap.org/
Cadila Corporate Campus
Sarkhej-Dholka Road,
Bhat, Ahmedabad-382 210, INDIA
Phone : +91-2718-225001 (15 Lines)
Fax :+91-2718-225039
e-mail : response@cadilapharma.co.in
http://www.polycap.org/
Before the study is made public, one should have asked the principle investigation authorities to answer few question which are missing in the study and like all Indian researches created doubt.
ReplyDelete# how many deaths occurred while under trail.
# how many drop outs in the study for want of any factor.
# does doctors were not using these drugs before the magic pill.
# any cross check of subjects studied for their reliability - does they in actual exists.
# How much money paid to the subjects who offered their living body to trail.
# any amount insured for donating living body for study and does that amount paid to dead if any.
# Why the public institutions are less in number to private institutions offering study.
The data is missing from the tables of the published study and enforce any researcher to think a hypothetical study. Many more questions are to be asked and I wounder how a journal like India today accepted and made the study public.
I do hope I will get answer.
RIPUDAMAN SINGH
134-S, Sant Nagar,
Patiala 147001
Mobile: 09815200134
e-mail: ripu134@gmail.com
Before I could place any comments I wish to know the detailed address of institution involved in clinical research in Punjab. few are known to me like CMC Ludhiana, PGI, Chandiharh and Sadbhavna Medical, Patiala. Among us may friends were trail subjects for PloyCap clinical research.
ReplyDeleteMeder
Gurdaspur
meder@aol.in
PLS I AM A STUDENT OF PHARMACY I NEED CONTACT NO OR EMAIL FOR DR ARUN MASEEH
ReplyDeleteIT'S VERY URGENT FOR ME PLS HELP ME
JIGAR SONI
No one reply any posting and authorities do not like to speakout.
ReplyDelete